Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • General
  • News

“Health And Human Services Report Says Mask Mandates Should Be Reinstated To Help ‘Long Covid'” – NYPost

By Benzinga Newsdesk
Today, 2:27 AM
Not this again. Masks and social distancing should be mandated or encouraged in public to protect people from possible “long COVID”, a new Department of Health and Human Services report

AHPI

Read More
1 minute read
  • Biotech
  • General
  • News

White House Coronavirus Response Coordinator Ashish Kumar Jha Says Vaccines Effective Against New Coronavirus Subvariants

By Benzinga Newsdesk
Today, 2:27 AM
- Reuters

AZN

Read More
4 minute read
  • Biotech
  • Commodities
  • Earnings
  • FDA
  • General
  • Guidance
  • Health Care
  • Large Cap
  • M&A
  • Management
  • Markets
  • Media
  • News
  • Small Cap
  • Tech
  • Top Stories

Jack Ma’s Ant Group Slapped With $1B Fine, Carl Icahn’s Huge Short Position In GameStop, Novavax Culls COVID-19 Vaccine Alliance With GAVI: Top Stories Tuesday, Nov. 22

By Vandana Singh
Today, 2:27 AM
Reuters

AMZN

Read More
1 minute read
  • News

Novavax Says Co. Has Not Incurred Any Termination Penalties In Connection With Termination Of APA, Says Had Only Received Orders Under APA For ~2M Doses

By Michael Horton
Today, 2:27 AM
-Reuters

NVAX

Read More
1 minute read
  • News

Novavax Says On Nov. 18, 2022 Co. Delivered Written Notice To Gavi Alliance To Terminate, Effective Immediately, Advance Purchase Agreement Dated May 5, 2021

By Michael Horton
Today, 2:27 AM
-Reuters

NVAX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Small Cap

Canada Approves Novavax’s COVID-19 Vaccine As Booster In Adults

By Vandana Singh
Today, 2:27 AM
Health Canada has granted expanded approval to Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (COVID-19 Vaccine as a homologous booster in adults aged 18 and older.

NVAX

Read More
1 minute read
  • Biotech
  • General
  • News

Biden Administration Official Says U.S. Will Renew Covid-19 Public Health Emergency Declaration In January

By Benzinga Newsdesk
Today, 2:27 AM
- Reuters   Nov 11 - The United States in January will extend the COVID-19 pandemic status as a public health emergency, allowing millions of Americans to keep getting free tests, vaccines and treatments until at

AZN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows

By Vandana Singh
Today, 2:27 AM
According to a report published in Nature Medicine, COVID-19-reinfected patients had a more than doubled risk of death and a…

AZN

Read More
1 minute read
  • FDA
  • News

Novavax Nuvaxovid Covid-19 Vaccine Authorized In The United Kingdom For Use As A Booster In Adults

By Benzinga Newsdesk
Today, 2:27 AM
Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products

NVAX

Read More
1 minute read
  • Earnings
  • News

Novavax Q3 EPS $(2.15) Misses $1.57 Estimate, Sales $734.58M Beat $586.25M Estimate

By Benzinga Newsdesk
Today, 2:27 AM
Novavax (NASDAQ:NVAX) reported quarterly losses of $(2.15) per share which missed the analyst consensus estimate of $1.57 by 236.94 percent. This is a 50.12 percent increase over losses of $(4.31) per share from the same

NVAX

Posts navigation

Previous 1 … 6 7 8 … 64 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service